Chemoinformaics analysis of P-Mentha-2,4(8)-Diene
| Molecular Weight | 136.238 | nRot | 0 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
| Exact Molecular Weight | 136.125 | nRing | 1 |
| Solubility: LogS | -4.085 | nHRing | 0 |
| Solubility: LogP | 3.895 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.479 |
| Synth | 3.834 |
| Natural Product Likeliness | 2.294 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.008 |
| HIA | 0.006 |
| CACO-2 | -4.403 |
| MDCK | 0.000019 |
| BBB | 0.374 |
| PPB | 0.930329 |
| VDSS | 3.917 |
| FU | 0.0650153 |
| CYP1A2-inh | 0.427 |
| CYP1A2-sub | 0.585 |
| CYP2c19-inh | 0.148 |
| CYP2c19-sub | 0.915 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.493 |
| CYP2d6-inh | 0.274 |
| CYP2d6-sub | 0.891 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.579 |
| CL | 11.686 |
| T12 | 0.692 |
| hERG | 0.033 |
| Ames | 0.012 |
| ROA | 0.061 |
| SkinSen | 0.928 |
| Carcinogencity | 0.84 |
| EI | 0.935 |
| Respiratory | 0.928 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.938956 |